MHRA

approved-1280

First anti-seizure medication for rare epileptic disorder approved

Ganaxolone (Ztalmy) treats cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder.

14 Mar 2024

safety-alert-summary

New valproate safety materials released by MHRA

Updated regulatory measures are now in place to reduce the known harms from valproate.

09 Feb 2024

main pic spread copy.jpg

Key clinical developments in 2021

This module provides an update of the major developments in pharmacy practice during 2021.

16 Dec 2021

blister-pack-empty-drug-shortages-medicine-tablets-summary.jpg

MHRA launches Covid-19 Yellow Card reporting site

The MHRA has launched a new Yellow Card reporting site specifically for Covid-19 healthcare products.

06 May 2020

Change privacy settings